Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFSAN Seeks Recommendations On Fiscal 2008 Priorities

This article was originally published in The Tan Sheet

Executive Summary

FDA's Center for Food Safety and Applied Nutrition is seeking comments on its fiscal 2008 priorities as it starts the final quarter of a year in which it achieved multiple significant goals

You may also be interested in...



Request For NDI Input May Portend Much Anticipated Guidance – Industry

FDA again requests industry input on how to "enhance the quality" of its pre-market notification system for new dietary ingredients - a move that could be a step either toward or away from issuing much anticipated draft guidance, industry stakeholders say

Request For NDI Input May Portend Much Anticipated Guidance – Industry

FDA again requests industry input on how to "enhance the quality" of its pre-market notification system for new dietary ingredients - a move that could be a step either toward or away from issuing much anticipated draft guidance, industry stakeholders say

Request For NDI Input May Portend Much Anticipated Guidance – Industry

FDA again requests industry input on how to "enhance the quality" of its pre-market notification system for new dietary ingredients - a move that could be a step either toward or away from issuing much anticipated draft guidance, industry stakeholders say

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS100675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel